Sonova Holding (OTCMKTS:SONVY – Get Free Report) saw a significant growth in short interest in July. As of July 15th, there was short interest totaling 1,508 shares, a growth of 75.8% from the June 30th total of 858 shares. Based on an average daily trading volume, of 36,640 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are short sold.
Sonova Price Performance
SONVY traded up $0.07 on Friday, hitting $54.63. The company had a trading volume of 11,034 shares, compared to its average volume of 14,025. Sonova has a 1 year low of $42.26 and a 1 year high of $61.09. The company’s fifty day moving average price is $50.77 and its 200 day moving average price is $49.76. The company has a quick ratio of 1.43, a current ratio of 1.75 and a debt-to-equity ratio of 0.51.
Wall Street Analyst Weigh In
Several analysts have recently issued reports on the stock. Citigroup reiterated a “sell” rating on shares of Sonova in a research report on Friday, July 24th. Morgan Stanley upgraded Sonova from an “underweight” rating to an “equal weight” rating in a report on Tuesday, June 23rd. Finally, UBS Group upgraded Sonova from a “hold” rating to a “buy” rating in a research note on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold”.
Sonova Company Profile
Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.
Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.
Featured Articles
- Five stocks we like better than Sonova
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.
